Literature DB >> 6606012

A novel HLA-D/DR-like antigen specific for human B lymphoid cells. Biochemical evidence for similarity to but nonidentity with known HLA-D/DR antigens.

G E Marti, M C Kuo, S Shaw, C C Chang, R Demars, J A Sogn, J E Coligan, T J Kindt.   

Abstract

The polymorphic human B cell-specific antigen, 33.1, detected by a murine monoclonal antibody, was compared by genetics and structural analysis with known human Ia antigens from a panel of DR homozygous Epstein-Barr virus-transformed B lymphoblastoid cell lines. Cells homozygous for DR 1, 2, 4, 5, and w6 were positive, while cells that are DR3,3 or DR7,7 usually failed to express this antigen. Mutant DR null, DC/MB-positive cells were 33.1 positive while DR null, DC/MB-negative cells failed to express this antigen, suggesting the segregation of 33.1 with the DC antigen. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis revealed that 33.1 alpha and beta chains were of lower molecular weights than the DR alpha and beta chains isolated from the same cell line. Partial N-terminal amino acid sequence analyses were carried out for the heavy and light chains of the 33.1 antigen radiolabeled with [3H] phenylalanine. The results of these analyses, in conjunction with previous data on tissue distribution, indicate that the 33.1 antigen is a non-DR but Ia-like antigen closely related to the previously defined I-A homologues, DC and DS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606012      PMCID: PMC2187152          DOI: 10.1084/jem.158.6.1924

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  Further studies on the differences in serum dependence in EBV negative lymphoma lines and their in vitro EBV converted, virus-genome carrying sublines.

Authors:  M Steinitz; G Klein
Journal:  Eur J Cancer       Date:  1977-11       Impact factor: 9.162

2.  Structural studies of murine I-E and human DR antigens.

Authors:  J Silver; L E Walker; R A Reisfeld; M A Pellegrino; S Ferrone
Journal:  Mol Immunol       Date:  1979-01       Impact factor: 4.407

3.  Regeneration of transplantation antigens on mouse cells.

Authors:  B D Schwartz; S G Nathenson
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

4.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

5.  Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line.

Authors:  R DeMars; C C Chang; R A Rudersdorf
Journal:  Hum Immunol       Date:  1983-10       Impact factor: 2.850

6.  Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells.

Authors:  P Kavathas; F H Bach; R DeMars
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

7.  Purification of immunologically active HLA-A and -B antigens by a series of monoclonal antibody columns.

Authors:  P Parham
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

8.  Molecular characterization of HLA-A, B homologues in owl monkeys and other nonhuman primates.

Authors:  P Parham; H L Ploegh
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

9.  Lymphoblastoid cell lines from patients with chronic lymphocytic leukemia: identification of tumor origin by idiotypic analysis.

Authors:  J N Hurley; S M Fu; H G Kunkel; G McKenna; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

10.  Polymorphism and complexity of the human DC and murine I-A alpha chain genes.

Authors:  C Auffray; A Ben-Nun; M Roux-Dosseto; R N Germain; J G Seidman; J L Strominger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  8 in total

1.  Highly polymorphic products of both HLA-DR and HLA-DQ genes contribute to the polymorphism of the HLA-DRw13 haplotype.

Authors:  J Michon; Y Henin; G Sterkers; C Freidel; L Gebuhrer; H Betuel; J Y Muller; J P Levy
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Functional definition of HLA-DR and -DQ epitopes specific for DR2-short, DwFJO haplotype.

Authors:  D Zeliszewski; G Sterkers; C Freidel; L Gebuhrer; H Betuel; J P Levy
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  An antiviral T-cell clone defines a functional supertypic specificity shared by different HLA-DR molecules from DR2-short, DRw11, and DRw13 haplotypes.

Authors:  D Zeliszewski; G Sterkers; J Choppin; C Freidel; L Gebuhrer; H Betuel; J P Levy
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  Specificity of the HLA class II reactive monoclonal antibody 33.1.

Authors:  X M Li; J A Sogn; J E Coligan; M C Kuo; G E Marti; L J Edison; T J Kindt
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

5.  Primary structural sequence polymorphism in the human class II MHC antigen 33.1.

Authors:  M C Kuo; X M Li; G E Marti; J A Sachs; J A Sogn; J E Coligan; T J Kindt
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  Separation of four class II molecules from DR2 and DRw6 homozygous B lymphoid cell lines.

Authors:  H Maeda; R Hirata
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate.

Authors:  E Smeland; T Godal; E Ruud; K Beiske; S Funderud; E A Clark; S Pfeifer-Ohlsson; R Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Lymphocytic lymphoma/B-chronic lymphocytic leukaemia--an immunohistopathological study of peripheral B lymphocyte neoplasia.

Authors:  S H Swerdlow; L J Murray; J A Habeshaw; A G Stansfeld
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.